医学
合生元
代谢综合征
肠道菌群
炎症
病态的
肥胖
胰岛素抵抗
内科学
失调
全身炎症
微生物群
糖尿病
免疫学
益生菌
生物
细菌
遗传学
作者
Diana Rodríguez-Vera,Arely Vergara-Castañeda,Diana K Lazcano-Orozco,Gabriela Ramírez-Vélez,Alonso Vivar-Sierra,María José Araiza-Macías,José Patricio Hernández-Contreras,Carlos Rogelio Naranjo-Navarro,Juan Rodrigo Salazar,Marco A. Loza-Mejía,Rodolfo Pinto-Almazán
出处
期刊:Metabolic Syndrome and Related Disorders
[Mary Ann Liebert]
日期:2021-11-01
卷期号:19 (9): 469-482
被引量:2
标识
DOI:10.1089/met.2021.0022
摘要
The metabolic syndrome (MetS) includes numerous interrelated clinical, anthropometric, biochemical, and metabolic components and has become a public health problem due to its impact on morbimortality. Inflammation is a central mechanism underlying the etiology and clinical manifestations of MetS, contributing to its related pathological outcomes. Dietary patterns have been associated with the promotion of the diversity of microbiota in the digestive tract. Recently, research has focused on the importance of microbiota changes associated with MetS and inflammation. Other studies have been performed to understand the impact of prebiotics, probiotics, and synbiotics as allies on diet, inflammation, and MetS parameters. This review analyses the correlation between metabolic disorders, inflammation parameters, gut microbiota, and how diet has been involved as treatment of MetS and the modulation of inflammation and microbiota.
科研通智能强力驱动
Strongly Powered by AbleSci AI